Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance - Pfarr, Nicole; Penzel, Roland; Endris, Volker; Lier, Clemens; Flechtenmacher, Christa; Volckmar, Anna-Lena; Kirchner, Martina; Leichsenring, Jonas; Herpel, Esther; Schneeweiss, Andreas; Schirmacher, Peter; Sinn, Peter; et al. (Genes, chromosomes & cancer, 2017)
First published: 28 October 2016